Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
80 participants
INTERVENTIONAL
2005-05-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury
NCT02027246
Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury
NCT03521336
NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI
NCT02688062
Intrathecal Transplantation of UC-MSC in Patients With Early Stage of Chronic Spinal Cord Injury
NCT03521323
Stem Cell Therapy in Spinal Cord Injury
NCT02009124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BM transplant with physiotherapy
Autologous BM transplant
Autologous bone marrow transplant
Physical therapy
Physiotherapy only
conventional physical therapy for chronic spinal cord injury.
Physical therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autologous bone marrow transplant
Physical therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No concomitant systemic disease
* No progress on physiotherapy for at least 6 months
* Duration of injury from 10 months to 3 years
Exclusion Criteria
* Concomitant systemic disease
* Progress can be observed on physiotherapy
* Acute injury or duration of injury less than 10 months
10 Years
36 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Medical Military Academy, Egypt
UNKNOWN
Alexandria University
OTHER
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cairo University, and the Cancer Institute of New Jersey, UMDNJ/RWJMS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University School of Medicine
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
El-Kheir WA, Gabr H, Awad MR, Ghannam O, Barakat Y, Farghali HA, El Maadawi ZM, Ewes I, Sabaawy HE. Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients. Cell Transplant. 2014 Apr;23(6):729-45. doi: 10.3727/096368913X664540. Epub 2013 Feb 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EGY-SCI-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.